News

Ciclesonide, Nycomed’s proprietary corticosteroid, has a unique activation mechanism and is the active ingredient in Alvesco HFA (hydrofluoroalkane) Inhalation Aerosol MDI (metered-dose inhaler) for the treatment of asthma

As a result of this acquisition, MGI Pharma becomes a wholly-owned subsidiary of Eisai Corporation of North America. At the effective time of the merger, all outstanding shares

Champix is claimed to be Japan’s first oral smoking cessation aid developed for smoking cessation treatment. Current ‘nicotine replacement therapy’ relieves withdrawal symptoms associated with smoking cessation by

The transaction also includes five-year warrants to purchase 3.5 million shares of common stock at an exercise price of $3 per share. The transaction is expected to raise

The study has confirmed that the catheter provides highly acceptable flow rates at modest negative pressure without deterioration in flow rate over seven weeks of use, even with

The pivotal study, Serene, investigated patients suffering from rheumatoid arthritis (RA) who had an inadequate response to methotrexate (MTX) therapy, a commonly used RA drug. The study successfully

The $25 million facility more than doubles the previous MDS Phase I capacity in Phoenix to 420 total beds to meet the growing needs of its pharmaceutical and

Under the terms of the settlement, Glaxo has agreed not to assert its patent against Cypress’s new alcohol-free formulation of its generic ranitidine oral syrup. Cypress expects to

Douglass Simpson, Corgenix’s president and CEO, said: “In the quarter ended December 31, 2007, we continued to add important new customers in the US and internationally, and we